 cytotox chemotherapi induc differenti small-cel lung carcinoma high respons rate chemotherapi major small-cel lung cancer sclc patient chemoresist tumor phenotyp chang precursor chemoresist statu role chemotherapi chang tumor sampl patient chemotherapi etoposid doxorubicin cyclophosphamid onset chemoresist cours chemotherapi histolog chang minor patient increas cell size major patient appear mix composit tumor neuroendocrin NE epidermoid glandular compon mix major chang good respons ultrastructur studi increas neurosecretori granul desmosom high frequenc multidirect differenti comparison pretherapi sampl immunohistochem IH analysi increas cytokeratin CK express treat patient differ label pattern express molecular weight CK express NE lineag marker leu Sy SL stabl NE differenti marker leu chromogranin treat patient neuron-specif enolas nse activ stabl treat sclc larg cell differenti phenotyp prolif capac Ki label characterist treat secondari chemoresist sclc acquisit complex phenotyp primari respons drug-induc differenti sclc